Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

273.21 USD -2.63 (-0.95%)
Streaming Delayed Price Updated: 2:27 PM EST, Jan 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Biogen, Inc.

< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
What to Watch in the Day Ahead - Wednesday, Jan 27
(The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at . Thomson One users... 
Tags companyNews
From Reuters: Company News
Noteworthy Tuesday Option Activity: BIIB, RL, SEE
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Biogen Inc (BIIB), where a total volume of 8,877 contracts has been traded thus far... 
Tags Stocks
From Market News Video
VUG, MA, CELG, BIIB: Large Outflows Detected at ETF
Symbols mentioned in this story: VUG, MA, CELG, BIIB Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Biogen Inc. Earnings Preview: What Option Traders Are Expecting From BIIB Stock
 
Tags Trading Advice NASDAQ:BIIB
From InvestorPlace
Goldman: Here are the stocks to buy if you fear a U.S. recession
If you’re fear the economy is starting to contract, Goldman Sachs strategists suggest buying stocks with strong balance sheets and limited exposure to overseas markets. That includes stocks like... 
Tags Industrial Products & Services Economy Insurance
From MarketWatch
Big Earnings Expectations For Big Biotech
Three leading biotech companies are expected to post quarterly results this week. Analysts are looking for earnings growth from Amgen ... 
Tags Earnings Trading Ideas Previews
From Benzinga
Apple, Amazon headline crucial week for Wall Street quarterly results
Tech earnings figure heavily this week with reports from Apple Inc. and Microsoft Corp., along with 10 other Dow industrial components, as investors try to divine the Federal Reserve’s intentions... 
Tags CAT HAL HON
From MarketWatch
Barclays Prefers Biogen Over Celgene Heading Into Q4 Results
Biogen Inc (NASDAQ: BIIB) shares have lost 12 percent since December 22, while shares of Celgene Corporation (NASDAQ: CELG) are ... 
Tags Trading Ideas Analyst Ratings Reiteration
From Benzinga
Biotech Rally Underway After Hitting 52 Week Low Today… Update-After Close
Biotech stocks reversed course about noon after the worse start in many years. 
Tags Stocks / Equities Pharma/Biotech ETF's
From Blogs - TalkMarkets
Credit Suisse Bullish On Most Big Pharma Names
Credit Suisse’s Alethia Young initiated coverage of several major pharmaceutical companies, commenting on their valuations, ... 
Tags CELG XNPT CHRS
From Benzinga
Why This Analyst Is Cautious On Biogen
Biogen Inc (NASDAQ: BIIB) are down 12 percent since January 4, and trading close to their 52-week low. Credit ... 
Tags Alethia Young Credit Suisse Analyst Color
From Benzinga
The Weekly Play: Sell Calls on This Sector (IBB)
 
Tags NASDAQ:GILD Trading Advice NASDAQ:IBB
From InvestorPlace
Biogen Ticks Up Following EU Marketing Authorization Of Benepali
Shares of Biogen Inc (NASDAQ: BIIB) were trading higher by 2 percent at $279.00 early Tuesday morning after the company announced ... 
Tags Benzinga Health Care News
From Benzinga
Valuation Models For Large Cap Biopharma Stocks In A Bear Market
We have been in a bear market for biotechnology stocks since September 2015 despite a Q4 rally; now add to that the recent 2016 YTD correction of 16% bringing prices topre-bubble lows 
Tags Healthcare Stocks / Equities
From Blogs - TalkMarkets
4 Biotech Stocks Looking Good this Earnings Season
Given the large number of biotech participants, pinpointing stocks that have the potential to beat estimates could appear to be a daunting task. 
Tags Stocks / Equities Pharma/Biotech Healthcare
From Blogs - TalkMarkets
Biogen, Samsung JV Announces Etanercept Biosimilar Referencing Enbrel, BENEPALI, Approved in EU
The joint venture between Biogen (NASDAQ: BIIB) and Samsung BioLogics, Samsung Bioepis, has been granted ... 
Tags Press Releases News BIIB
From Benzinga
Samsung Bioepis' Enbrel drug copy gets EU approval
SEOUL, Jan 17 (Reuters) - Samsung Bioepis Co Ltd said on Sunday it had received European Commission approval for its copy of the blockbuster biotech arthritis drug Enbrel. 
Tags companyNews
From Reuters: Company News
Major drugmakers push back in U.S. price debate
SAN FRANCISCO, Jan 15 (Reuters) - With a backlash brewing over the price of medicines in the United States, drugmakers are pushing back with a new message: Most people don't pay retail. 
Tags companyNews
From Reuters: Company News
10 biotech stocks to buy at ‘silly’ cheap prices
The industry is healthier than ever, and three main concerns don’t pan out, writes Michael Brush. 
Tags General BLUE ONTY
From MarketWatch
7 Battered Biotech Stocks: Bargains or Busts?
 
Tags NASDAQ:REGN NASDAQ:ALXN NASDAQ:CELG
From InvestorPlace
High drug prices bring forth innovation: Scangos
While the biotech sector has been under fire for high drug prices, Biotech CEO says that it brings innovations. 
Tags Biogen Inc Biotechnology Health Care/Pharmaceuticals Biotechnology and Life Sciences
From CNBC.com News
5 Biotech Stocks Ready To Crush The Market In 2016
The start of a brand new year looks to be the right time to focus on some biotech stocks with strong fundamentals and good prospects. Here’s a look at five such stocks. 
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
This Week Is Paramount For Biotech Stocks
The Biotechnology sector has been wracked with uncertainty over the past year as market turmoil has weighed on the industry as a ... 
Tags Biotech Stocks Biotech BIIB
From Benzinga
Can Large Cap Biopharmaceutical Stocks Outperform In 2016?
With this post we summarize selected Sales and Earnings metrics of important large cap biotech stocks for the purpose of analysis after the J.P. Morgan Healthcare Conference and after 2015 financial... 
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
Agree To Buy Biogen At $160, Earn 6.1% Using Options
Investors eyeing a purchase of Biogen Inc (BIIB) stock, but cautious about paying the going market price of $284.91/share, might benefit from considering selling puts among the alternative strategies... 
Tags Stocks
From Market News Video
Jim Cramer Gives His Opinion On Lockheed Martin And Gilead Sciences
OnCNBC's Mad Money, Jim Cramer said that he likes Lockheed Martin Corporation (NYSE: LMT). Despite positive news about the ... 
Tags Jim Cramer AMGN BIIB
From Benzinga
Trade of the Day: Biogen (BIIB)
 
Tags NASDAQ:BIIB Trading Advice NYSE:PFE
From InvestorPlace
Jefferies' Best Biotech Ideas For 2016 (And Beyond)
In a report issued Wednesday, Jefferies’ Biotechnology Equity Research Team shared its outlook, key themes and best ideas in ... 
Tags RXDX BCRX Biotech
From Benzinga
These are the biotech stocks to own next year: Pro
RBC Capital Markets analyst Michael Yee says there are three biotech stocks to own next year no matter how the sector performs next year. 
Tags Celgene Corp Vertex Pharmaceuticals Incorporated iShares Nasdaq Biotechnology ETF
From CNBC.com News
Noteworthy Tuesday Option Activity: GS, BIIB, AET
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Goldman Sachs Group, Inc. (GS), where a total of 17,333 contracts have traded so far,... 
Tags Stocks
From Market News Video
< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.